Modulating Drug Release from 3D Printed Pharmaceutical Products
Julian Quodbach
Heinrich Heine University Düsseldorf, Institute of Pharmaceutics and Biopharmaceutics, Building 26.22.00.38, Universitätsstr. 1, 40225, Düsseldorf, Germany
Search for more papers by this authorJulian Quodbach
Heinrich Heine University Düsseldorf, Institute of Pharmaceutics and Biopharmaceutics, Building 26.22.00.38, Universitätsstr. 1, 40225, Düsseldorf, Germany
Search for more papers by this authorMohammed Maniruzzaman
School of Life Sciences, University of Sussex, Brighton, UK, BN1 9QG
Search for more papers by this authorSummary
Pharmaceutical dosage forms are complex devices to deliver active pharmaceutical ingredients to patients. This chapter explores the pharmaceutically used three-dimensional (3D) printing processes and techniques. The process flow of 3D printing processes is similar for all printing techniques. Inkjet printing is the process of jetting small droplets of ink on a substrate. The common characteristic of extrusion-based printing is the forced movement of plasticized material through a nozzle and the deposition of the extruded material on a printing bed. Stereolithography and selective laser sintering utilize lasers to solidify materials to 3D objects. The chapter focuses on modifying the drug release profile from 3D printed dosage forms. 3D printing offers several approaches to modify the release profile from dosage forms. The formulation development of semisolids for pressure-assisted microsyringes-based printing is less demanding compared to fused filament fabrication.
References
- Sorkin, E.M., Clissold, S.P., and Brogden, R.N. (1985). Nifedipine a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 30 (3): 182–274.
-
Dwyer, M.S., Levy, R.A., and Menander, K.B. (1986). Compliance through the use of modern dosage forms. Journal of Pharmacy Technology
2 (4): 166–170.
10.1177/875512258600200407 Google Scholar
- Institute, N.H.G.R. (2016). The cost of sequencing a human genome. https://www.genome.gov/27565109/the-cost-of-sequencing-a-human-genome/ (accessed 06 November 2017).
- Schork, N. (2015). Personalized medicine: time for one-person trials. Nature 520 (7549): 609–611.
- Goole, J. and Amighi, K. (2016). 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. International Journal of Pharmaceutics 499 (1–2): 376–394.
-
Zema, L., Melocchi, A., Maroni, A. et al. (2017). Three-dimensional printing of medicinal products and the challenge of personalized therapy. Journal of Pharmaceutical Sciences
106 (7): 1697–1705.
10.1016/j.xphs.2017.03.021 Google Scholar
- Norman, J., Madurawe, R., Moore, C.M.V. et al. (2016). A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Advanced Drug Delivery Reviews 108: 39–50.
- Hull, C.W. (1986). Apparatus for production of three-dimensional objects by stereolithography. US Patent 4, 575,330 and issued 11 March 1986.
- Gittard, S. and Narayan, R. (2010). Laser direct writing of micro- and nano-scale medical devices. Expert Review of Medical Devices 7 (3): 343–356.
- Water, J.J., Water, J.J., Bohr, A. et al. (2015). Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material. Journal of Pharmaceutical Sciences 104 (3): 1099–1107.
- Holländer, J., Genina, N., Jukarainen, H. et al. (2016). Three-dimensional printed PCL-based implantable prototypes of medical devices for controlled drug delivery. Journal of Pharmaceutical Sciences 105 (9): 2665–2676.
- Kempin, W., Franz, C., Koster, L.-C. et al. (2017). Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants. European Journal of Pharmaceutics and Biopharmaceutics 115: 84–93.
- Zhang, J., Feng, X., Patil, H. et al. (2016). Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. International Journal of Pharmaceutics 519 (1–2): 186–197.
- Alhijjaj, M., Belton, P., and Qi, S. (2016). An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. European Journal of Pharmaceutics and Biopharmaceutics 108: 111–125.
- Fina, F., Goyanes, A., Gaisford, S. et al. (2017). Selective laser sintering (SLS) 3D printing of medicines. International Journal of Pharmaceutics 529 (1–2): 285–293.
- Wang, J., Goyanes, A., Gaisford, S. et al. (2016). Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. International Journal of Pharmaceutics 503 (1–2): 207–212.
- Nernst, W. (1903). Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen. Zeitschrift für Physikalische Chemie 47: 52–55.
- Brunner, E. (1903). Reaktionsgeschwindigkeit in heterogenen Systemen. Zeitschrift für Physikalische Chemie 47: 56–102.
- Higuchi, T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences 52 (12): 1145–1149.
- Higuchi, T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. Journal of Pharmaceutical Sciences 50 (10): 874–875.
- Lapidus, H. and Lordi, N.G. (1968). Drug Release from Compressed Hydrophilic Matrices. Journal of Pharmaceutical Sciences 57 (8): 1292–1301.
- Hixson, A.W. and Crowell, J.H. (1931). Dependence of reaction velocity upon surface and agitation. Industrial and Engineering Chemistry 23 (8): 923–931.
- Goyanes, A., Robles Martinez, P., Buanz, A. et al. (2015). Effect of geometry on drug release from 3D printed tablets. International Journal of Pharmaceutics 494 (2): 657–663.
- Reynolds, T.D., Mitchell, S.A., and Balwinski, K.M. (2002). Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Development and Industrial Pharmacy 28 (4): 457–466.
- Pietrzak, K., Isreb, A., and Alhnan, M. (2015). A flexible-dose dispenser for immediate and extended release 3D printed tablets. European Journal of Pharmaceutics and Biopharmaceutics 96: 380–387.
- Kyobula, M., Adedeji, A., Alexander, M. et al. (2017). 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release. Journal of Controlled Release 261: 207–215.
- Katstra, W.E., Palazzolo, R.D., Rowe, C.W. et al. (2000). Oral dosage forms fabricated by Three Dimensional Printing™. Journal of Controlled Release 66 (1): 1–9.
- Rowe, C.W., Katstra, W.E., Palazzolo, R.D. et al. (2000). Multimechanism oral dosage forms fabricated by three dimensional printing™. Journal of Controlled Release 66 (1): 11–17.
- Yu, D.G., Yu, D.-G., Branford-White, C. et al. (2009). Novel drug delivery devices for providing linear release profiles fabricated by 3DP. International Journal of Pharmaceutics 370 (1–2): 160–166.
- Gioumouxouzis, C., Katsamenis, O., Bouropoulos, N. et al. (2017). 3D printed oral solid dosage forms containing hydrochlorothiazide for controlled drug delivery. Journal of Drug Delivery Science and Technology 40: 164–171.
- Goyanes, A., Wang, J., Buanz, A. et al. (2015). 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Molecular Pharmaceutics 12 (11): 4077–4084.
-
Okwuosa, T., Pereira, B., Arafat, B. et al. (2017). Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centered therapy. Pharmaceutical Research
34 (2): 427–437.
10.1007/s11095-016-2073-3 Google Scholar
- Khaled, S., Burley, J., Alexander, M. et al. (2015). 3D printing of tablets containing multiple drugs with defined release profiles. International Journal of Pharmaceutics 494 (2): 643–650.